Cannell & Co. Amgen Inc Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Amgen Inc stock. As of the latest transaction made, Cannell & Co. holds 8,055 shares of AMGN stock, worth $2.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

8,055

Previous 8,055 -0.0%

Holding current value

$2.6 Million

Previous $2.16 Million 7.21%

% of portfolio

0.08%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $5,644 - $6,880	-25 Reduced 0.31%	8,055 $1.95 Million
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $314,916 - $400,138	-1,375 Reduced 14.54%	8,080 $2.12 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $273,841 - $308,843	1,220 Added 14.81%	9,455 $2.13 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $79,552 - $91,040	-400 Reduced 4.63%	8,235 $1.85 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $329,018 - $385,485	-1,550 Reduced 15.22%	8,635 $1.84 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $32,457 - $38,650	-150 Reduced 1.45%	10,185 $2.34 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $11,732 - $13,047	-50 Reduced 0.48%	10,335 $2.63 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $29,671 - $36,411	-150 Reduced 1.42%	10,385 $2.45 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $72,896 - $96,680	-400 Reduced 3.66%	10,535 $2.14 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $434,088 - $489,312	2,400 Added 28.12%	10,935 $2.08 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $17,840 - $20,825	-100 Reduced 1.16%	8,535 $1.66 Million
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $9,264 - $10,444	-50 Reduced 0.58%	8,635 $1.79 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $25,318 - $28,288	150 Added 1.76%	8,685 $1.51 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $1.43 Million - $1.63 Million	8,535	8,535 $1.59 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account